The treatment of cancer-associated venous thromboembolic disease is complex due to an increased risk of thrombotic recurrence and bleeding under treatment. During the first 6 months, low molecular...

In an oncologic population with catheter, upper extremity vein thrombosis (UEVT) is a frequent complication, occurring in 2% to 6% of cancer patients with central venous catheters. UEVT is less...